Table 3.

Odds ratios from logistic regression models predicting at-risk levels of biomarkers (in 2000) by ApoE2 and ApoE4 carrier status

		ApoE2 carrier ^§	ApoE4 carrier ^§
	N	OR (95% CI)	OR (95% CI)
Biomarker outcome
Body mass index (>30 kg/m²)	1019	1.43 (0.77-2.66)	0.96 (0.48-1.93)
Waist-hip ratio (males: ≥0.95; females: ≥0.80)	1017	0.94 (0.61-1.45)	1.02 (0.66-1.59)
Systolic blood pressure (≥140 mm Hg)	1020	1.03 (0.73-1.46)	1.03 (0.72-1.47)
Diastolic blood pressure (≥90 mm Hg)	1020	1.14 (0.78-1.67)	1.09 (0.74-1.62)
Total cholesterol (≥240 mg/dl)	1020	0.45 (0.25-0.83)^†	1.14 (0.71-1.84)
High-density lipoprotein cholesterol (<40 mg/dl)	1020	0.45 (0.29-0.71)^†	1.26 (0.86-1.56)
Triglycerides (≥200 mg/dl)	1020	1.29 (0.77-2.17)	1.03 (0.58-1.81)
C-reactive protein (≥3 mg/l)	1000	1.08 (0.73-1.58)	0.62 (0.39-0.96)^†
Interleukin-6 (≥4.64 pg/ml)	1004	1.05 (0.68-1.64)	0.62 (0.37-1.04)^‡

OR=odds ratio; CI=confidence interval

Adjusts for age, sex, and rural/urban residence

^§

vs. non-carrier (ref group)

^†

p<.05

^‡

p<.10